Cao, Ziyi, et al. “Behavior and Consequences of COVID-19-Related Voluntary Disclosure: Evidence from Pharmaceutical Companies”. BCP Business & Management, vol. 31, Nov. 2022, pp. 378-91, https://doi.org/10.54691/bcpbm.v31i.2653.